1. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 2009;104:352-60. PMID:
19281467
2. Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 2009;103 Suppl 3:4-11. PMID:
19302497
3. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003;92:409-14. PMID:
12930430
4. Su L, Guess HA, Girman CJ, Jacobsen SJ, Oesterling JE, Panser LA, et al. Adverse effects of medications on urinary symptoms and flow rate: a community-based study. J Clin Epidemiol 1996;49:483-7. PMID:
8622001
5. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in america project: benign prostatic hyperplasia. J Urol 2008;179(5 Suppl):S75-80. PMID:
18405761
6. Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int 2005;96:77-82. PMID:
15963125
8. Parsons JK, Im R. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia. J Urol 2009;182:1463-8. PMID:
19683313
11. Gordon GG, Altman K, Southren AL, Rubin E, Lieber CS. Effect of alcohol (ethanol) administration on sex-hormone metabolism in normal men. N Engl J Med 1976;295:793-7. PMID:
958274
12. Araki H, Watanabe H, Mishina T, Nakao M. High-risk group for benign prostatic hypertrophy. Prostate 1983;4:253-64. PMID:
6189108
13. Bravi F, Bosetti C, Dal Maso L, Talamini R, Montella M, Negri E, et al. Food groups and risk of benign prostatic hyperplasia. Urology 2006;67:73-9. PMID:
16413336
15. Bunn F, Kirby M, Pinkney E, Cardozo L, Chapple C, Chester K, et al. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int J Clin Pract 2015;69:199-217. PMID:
25495905
16. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46:547-54. PMID:
15474261
17. Cornu JN, Lukacs B. Lower urinary tract symptoms in men: refocus on your patients. Eur Urol 2015;67:1110-1. PMID:
25840623
18. Haidinger G, Temml C, Schatzl G, Brössner C, Roehlich M, Schmidbauer CP, et al. Risk factors for lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology. Eur Urol 2000;37:413-20. PMID:
10765071
19. Pashootan P, Ploussard G, Cocaul A, de Gouvello A, Desgrandchamps F. Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort. BJU Int 2015;116:124-30. PMID:
25229124
21. Martin S, Lange K, Haren MT, Taylor AW, Wittert G; Members of the Florey Adelaide Male Ageing Study. Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men. J Urol 2014;191:130-7. PMID:
23770136
22. Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 2008;53:1228-35. PMID:
18358592
24. Choo MS, Han JH, Shin TY, Ko K, Lee WK, Cho ST, et al. Alcohol, smoking, physical activity, protein, and lower urinary tract symptoms: prospective longitudinal cohort. Int Neurourol J 2015;19:197-206. PMID:
26620903
25. Roberts RO, Tsukamoto T, Kumamoto Y, Rhodes T, Masumori N, Miyake H, et al. Association between cigarette smoking and prostatism in a Japanese community. Prostate 1997;30:154-9. PMID:
9122039
26. Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, et al. Risk behaviours and benign prostatic hyperplasia. BJU Int 2004;93:1241-5. PMID:
15180615
27. Narkiewicz K, van de Borne PJ, Hausberg M, Cooley RL, Winniford MD, Davison DE, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998;98:528-34. PMID:
9714109
28. Roberts RO, Jacobsen SJ, Rhodes T, Guess HA, Girman CJ, Panser LA, et al. Cigarette smoking and prostatism: a biphasic association? Urology 1994;43:797-801. PMID:
7515203
29. Rohrmann S, Fallin MD, Page WF, Reed T, Partin AW, Walsh PC, et al. Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins. Epidemiology 2006;17:419-27. PMID:
16699472
31. Hammarsten J, Högstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001;39:151-8. PMID:
11223674
32. Rohrmann S, Katzke VA, Kaaks R. Lifestyle and progression of lower urinary tract symptoms in German men-results from the EPIC-Heidelberg Cohort. Urology 2018;120:192-6. PMID:
29940234
35. de Groat WC. Influence of central serotonergic mechanisms on lower urinary tract function. Urology 2002;59(5 Suppl 1):30-6. PMID:
12007520